MIF and squamous cell carcinoma: In particular, MIF activation confers chemotherapeutic resistance, and its inhibition through MIF inhibitor 4‐IPP reverses chemotherapy resistance in SCCVII squamous carcinoma cells (Kindt et al., 2013; Yu et al., 2006).